Biggest News Aggregation in the World
📰 Stacy Roughan News

Stacy Roughan News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Stacy Roughan. Real-time updates on events, politics, business and more.

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease therapeutics, today announced that Dirk Thye, M.D., Quince’s Chief Executi...
Stacy Roughan Dirk Thye Quince Therapeutics Inc Therapeutics Inc Healthcare Life Sciences Conference Corporate Communications Investor Relations

Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX--Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today announced that it has retained MTS Health Partners, L.P. (MTS) as its financial ad...
Stacy Roughan David Lamond Exchange Commission Corporate Communications Investor Relations Health Partners Therapeutics Inc

Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX--Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today announced that its Board of Directors (the “Board”) unanimously approved the adopt...
Stacy Roughan Quince Therapeutics Inc Exchange Commission Therapeutics Inc Securities Exchange Corporate Communications Investor Relations

Cortexyme Appoints June Bray to its Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on rare and degenerative diseases, today announced the appointment of June Bray, a pharmaceutical industry veteran and global drug development and regulatory process expert, to the company...
June Bray David Lamond Stacy Roughan Cortexyme Inc Corporate Communications Investor Relations Hoechst Roussel Pharmaceuticals

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science